Forsta Ap Fonden Jazz Pharmaceuticals PLC Transaction History

Forsta Ap Fonden

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$114.26 - $136.0 $2.27 Million - $2.71 Million	-19,900 Reduced 90.45%	2,100 $258,000
Q3 2023 Oct 25, 2023	BUY	$122.0 - $145.31 $353,800 - $421,399	2,900 Added 15.18%	22,000 $2.85 Million
Q2 2023 Aug 03, 2023	BUY	$122.5 - $147.16 $2.34 Million - $2.81 Million	19,100 New	19,100 $2.37 Million
Q2 2022 Aug 11, 2022	SELL	$141.59 - $168.66 $14,159 - $16,866	-100 Reduced 4.76%	2,000 $312,000
Q1 2022 May 09, 2022	BUY	$129.64 - $160.7 $272,244 - $337,470	2,100 New	2,100 $327,000
Q4 2021 Feb 11, 2022	SELL	$119.87 - $145.67 $1.59 Million - $1.94 Million	-13,300 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$128.64 - $184.79 $1.71 Million - $2.46 Million	13,300 New	13,300 $1.73 Million
Q1 2021 May 11, 2021	SELL	$150.19 - $173.5 $195,247 - $225,550	-1,300 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$140.71 - $165.05 $182,923 - $214,565	1,300 New	1,300 $215,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Forsta Ap Fonden with notifications on news.